Evaluation of Platelet Activation in Depressed Patients With Ischemic Heart Disease After Paroxetine or Nortriptyline Treatment
- 1 April 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 20 (2), 137-140
- https://doi.org/10.1097/00004714-200004000-00004
Abstract
This study investigated the effects of antidepressant treatment on platelet activation in depressed patients with ischemic heart disease (IHD). Plasma levels of platelet α-granule release products β-thromboglobulin (BTG) and platelet factor 4 (PF4) were measured in 17 depressed patients with IHD who were treated in a 6-week, double-blind trial with either paroxetine (10 patients) or nortriptyline (7 patients). Baseline measurements of BTG and PF4 were significantly elevated in both drug treatment groups before the initiation of antidepressant therapy compared with those of healthy control subjects. In the paroxetine group, mean PF4 and BTG levels significantly decreased from these elevated baseline values within 1 week of treatment and remained low at 3- and 6-week measurements. In contrast, the nortriptyline group did not exhibit a significant decrease in PF4 or BTG plasma levels after 1, 3, or 6 weeks of treatment. Therefore, platelet activation in depressed patients with IHD seems to be inhibited by the selective serotonin reuptake inhibitor paroxetine. The effect of paroxetine on PF4 and BTG plasma levels suggests that it may reduce platelet aggregation in vivo and may positively impact IHD-related mortality in this population.Keywords
This publication has 15 references indexed in Scilit:
- The Relationship of Depression to Cardiovascular DiseaseArchives of General Psychiatry, 1998
- Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart diseaseBiological Psychiatry, 1997
- Exaggerated platelet reactivity in major depressionAmerican Journal of Psychiatry, 1996
- Depression in patients with coronary heart disease: A 12-month follow-upGeneral Hospital Psychiatry, 1996
- Depression and 18-Month Prognosis After Myocardial InfarctionCirculation, 1995
- The pathophysiological role of platelets during myocardial ischaemiaCardiovascular Research, 1994
- Depression following myocardial infarction. Impact on 6-month survivalJAMA, 1993
- Interaction between antidepressants and phosphoinositide signal transduction system in human plateletsBiological Psychiatry, 1993
- Robert Hanna Felix, M.D. 1904-1990American Journal of Psychiatry, 1991
- Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery diseaseAtherosclerosis, 1972